trial · primary record
Treprostinil Palmitil Inhalation Powder
Pulmonary Hypertension
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 344 |
| Primary completion | 2031-01-22 |
| Primary endpoint | Number of Participants Who Experienced at Least One Treatment-Emergent Adverse Events (TEAEs) |
| Registry ID | NCT07234032 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:16.808Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07234032
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.